 | • レポートコード：GIR-107A12384 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、不妊治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。不妊治療の種類別市場規模（女性用不妊検査、男性用不妊検査）、用途別市場規模（病院、クリニック、不妊治療センター、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・不妊治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck、Abbott、BioMerieux、BioZhena、Ferring Pharmaceuticals ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：女性用不妊検査、男性用不妊検査 ・用途別分析2016年-2026年：病院、クリニック、不妊治療センター、その他 ・不妊治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・不妊治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・不妊治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・不妊治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・不妊治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Infertility Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Infertility Therapies size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Infertility Therapies market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Infertility Therapies market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Female Infertility Testing
Male Infertility Testing
Market segment by Application, can be divided into
Hospitals
Clinics
Fertility Centers
Others
Market segment by players, this report covers
Merck
Abbott
BioMerieux
BioZhena
Ferring Pharmaceuticals
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Infertility Therapies
1.2 Classification of Infertility Therapies by Type
1.2.1 Overview: Global Infertility Therapies Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Infertility Therapies Revenue Market Share by Type in 2020
1.2.3 Female Infertility Testing
1.2.4 Male Infertility Testing
1.3 Global Infertility Therapies Market by Application
1.3.1 Overview: Global Infertility Therapies Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Fertility Centers
1.3.5 Others
1.4 Global Infertility Therapies Market Size & Forecast
1.5 Global Infertility Therapies Market Size and Forecast by Region
1.5.1 Global Infertility Therapies Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Infertility Therapies Market Size by Region, (2016-2021)
1.5.3 North America Infertility Therapies Market Size and Prospect (2016-2026)
1.5.4 Europe Infertility Therapies Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Infertility Therapies Market Size and Prospect (2016-2026)
1.5.6 South America Infertility Therapies Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Infertility Therapies Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Infertility Therapies Market Drivers
1.6.2 Infertility Therapies Market Restraints
1.6.3 Infertility Therapies Trends Analysis
2 Company Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Infertility Therapies Product and Solutions
2.1.4 Merck Infertility Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Merck Recent Developments and Future Plans
2.2 Abbott
2.2.1 Abbott Details
2.2.2 Abbott Major Business
2.2.3 Abbott Infertility Therapies Product and Solutions
2.2.4 Abbott Infertility Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Abbott Recent Developments and Future Plans
2.3 BioMerieux
2.3.1 BioMerieux Details
2.3.2 BioMerieux Major Business
2.3.3 BioMerieux Infertility Therapies Product and Solutions
2.3.4 BioMerieux Infertility Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 BioMerieux Recent Developments and Future Plans
2.4 BioZhena
2.4.1 BioZhena Details
2.4.2 BioZhena Major Business
2.4.3 BioZhena Infertility Therapies Product and Solutions
2.4.4 BioZhena Infertility Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 BioZhena Recent Developments and Future Plans
2.5 Ferring Pharmaceuticals
2.5.1 Ferring Pharmaceuticals Details
2.5.2 Ferring Pharmaceuticals Major Business
2.5.3 Ferring Pharmaceuticals Infertility Therapies Product and Solutions
2.5.4 Ferring Pharmaceuticals Infertility Therapies Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Ferring Pharmaceuticals Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Infertility Therapies Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Infertility Therapies Players Market Share
3.2.2 Top 10 Infertility Therapies Players Market Share
3.2.3 Market Competition Trend
3.3 Infertility Therapies Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Infertility Therapies Revenue and Market Share by Type (2016-2021)
4.2 Global Infertility Therapies Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Infertility Therapies Revenue Market Share by Application (2016-2021)
5.2 Infertility Therapies Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Infertility Therapies Revenue by Type (2016-2026)
6.2 North America Infertility Therapies Revenue by Application (2016-2026)
6.3 North America Infertility Therapies Market Size by Country
6.3.1 North America Infertility Therapies Revenue by Country (2016-2026)
6.3.2 United States Infertility Therapies Market Size and Forecast (2016-2026)
6.3.3 Canada Infertility Therapies Market Size and Forecast (2016-2026)
6.3.4 Mexico Infertility Therapies Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Infertility Therapies Revenue by Type (2016-2026)
7.2 Europe Infertility Therapies Revenue by Application (2016-2026)
7.3 Europe Infertility Therapies Market Size by Country
7.3.1 Europe Infertility Therapies Revenue by Country (2016-2026)
7.3.2 Germany Infertility Therapies Market Size and Forecast (2016-2026)
7.3.3 France Infertility Therapies Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Infertility Therapies Market Size and Forecast (2016-2026)
7.3.5 Russia Infertility Therapies Market Size and Forecast (2016-2026)
7.3.6 Italy Infertility Therapies Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Infertility Therapies Revenue by Type (2016-2026)
8.2 Asia-Pacific Infertility Therapies Revenue by Application (2016-2026)
8.3 Asia-Pacific Infertility Therapies Market Size by Region
8.3.1 Asia-Pacific Infertility Therapies Revenue by Region (2016-2026)
8.3.2 China Infertility Therapies Market Size and Forecast (2016-2026)
8.3.3 Japan Infertility Therapies Market Size and Forecast (2016-2026)
8.3.4 South Korea Infertility Therapies Market Size and Forecast (2016-2026)
8.3.5 India Infertility Therapies Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Infertility Therapies Market Size and Forecast (2016-2026)
8.3.7 Australia Infertility Therapies Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Infertility Therapies Revenue by Type (2016-2026)
9.2 South America Infertility Therapies Revenue by Application (2016-2026)
9.3 South America Infertility Therapies Market Size by Country
9.3.1 South America Infertility Therapies Revenue by Country (2016-2026)
9.3.2 Brazil Infertility Therapies Market Size and Forecast (2016-2026)
9.3.3 Argentina Infertility Therapies Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Infertility Therapies Revenue by Type (2016-2026)
10.2 Middle East & Africa Infertility Therapies Revenue by Application (2016-2026)
10.3 Middle East & Africa Infertility Therapies Market Size by Country
10.3.1 Middle East & Africa Infertility Therapies Revenue by Country (2016-2026)
10.3.2 Turkey Infertility Therapies Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Infertility Therapies Market Size and Forecast (2016-2026)
10.3.4 UAE Infertility Therapies Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Infertility Therapies Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Infertility Therapies Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Infertility Therapies Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Infertility Therapies Revenue (USD Million) by Region (2016-2021)
Table 5. Global Infertility Therapies Revenue Market Share by Region (2021-2026)
Table 6. Merck Corporate Information, Head Office, and Major Competitors
Table 7. Merck Major Business
Table 8. Merck Infertility Therapies Product and Solutions
Table 9. Merck Infertility Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Abbott Corporate Information, Head Office, and Major Competitors
Table 11. Abbott Major Business
Table 12. Abbott Infertility Therapies Product and Solutions
Table 13. Abbott Infertility Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. BioMerieux Corporate Information, Head Office, and Major Competitors
Table 15. BioMerieux Major Business
Table 16. BioMerieux Infertility Therapies Product and Solutions
Table 17. BioMerieux Infertility Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. BioZhena Corporate Information, Head Office, and Major Competitors
Table 19. BioZhena Major Business
Table 20. BioZhena Infertility Therapies Product and Solutions
Table 21. BioZhena Infertility Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Ferring Pharmaceuticals Corporate Information, Head Office, and Major Competitors
Table 23. Ferring Pharmaceuticals Major Business
Table 24. Ferring Pharmaceuticals Infertility Therapies Product and Solutions
Table 25. Ferring Pharmaceuticals Infertility Therapies Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Global Infertility Therapies Revenue (USD Million) by Players (2019-2021)
Table 27. Global Infertility Therapies Revenue Share by Players (2019-2021)
Table 28. Breakdown of Infertility Therapies by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Infertility Therapies Players Head Office, Products and Services Provided
Table 30. Infertility Therapies Mergers & Acquisitions in the Past Five Years
Table 31. Infertility Therapies New Entrants and Expansion Plans
Table 32. Global Infertility Therapies Revenue (USD Million) by Type (2016-2021)
Table 33. Global Infertility Therapies Revenue Share by Type (2016-2021)
Table 34. Global Infertility Therapies Revenue Forecast by Type (2021-2026)
Table 35. Global Infertility Therapies Revenue by Application (2016-2021)
Table 36. Global Infertility Therapies Revenue Forecast by Application (2021-2026)
Table 37. North America Infertility Therapies Revenue by Type (2016-2021) & (USD Million)
Table 38. North America Infertility Therapies Revenue by Type (2021-2026) & (USD Million)
Table 39. North America Infertility Therapies Revenue by Application (2016-2021) & (USD Million)
Table 40. North America Infertility Therapies Revenue by Application (2021-2026) & (USD Million)
Table 41. North America Infertility Therapies Revenue by Country (2016-2021) & (USD Million)
Table 42. North America Infertility Therapies Revenue by Country (2021-2026) & (USD Million)
Table 43. Europe Infertility Therapies Revenue by Type (2016-2021) & (USD Million)
Table 44. Europe Infertility Therapies Revenue by Type (2021-2026) & (USD Million)
Table 45. Europe Infertility Therapies Revenue by Application (2016-2021) & (USD Million)
Table 46. Europe Infertility Therapies Revenue by Application (2021-2026) & (USD Million)
Table 47. Europe Infertility Therapies Revenue by Country (2016-2021) & (USD Million)
Table 48. Europe Infertility Therapies Revenue by Country (2021-2026) & (USD Million)
Table 49. Asia-Pacific Infertility Therapies Revenue by Type (2016-2021) & (USD Million)
Table 50. Asia-Pacific Infertility Therapies Revenue by Type (2021-2026) & (USD Million)
Table 51. Asia-Pacific Infertility Therapies Revenue by Application (2016-2021) & (USD Million)
Table 52. Asia-Pacific Infertility Therapies Revenue by Application (2021-2026) & (USD Million)
Table 53. Asia-Pacific Infertility Therapies Revenue by Region (2016-2021) & (USD Million)
Table 54. Asia-Pacific Infertility Therapies Revenue by Region (2021-2026) & (USD Million)
Table 55. South America Infertility Therapies Revenue by Type (2016-2021) & (USD Million)
Table 56. South America Infertility Therapies Revenue by Type (2021-2026) & (USD Million)
Table 57. South America Infertility Therapies Revenue by Application (2016-2021) & (USD Million)
Table 58. South America Infertility Therapies Revenue by Application (2021-2026) & (USD Million)
Table 59. South America Infertility Therapies Revenue by Country (2016-2021) & (USD Million)
Table 60. South America Infertility Therapies Revenue by Country (2021-2026) & (USD Million)
Table 61. Middle East & Africa Infertility Therapies Revenue by Type (2016-2021) & (USD Million)
Table 62. Middle East & Africa Infertility Therapies Revenue by Type (2021-2026) & (USD Million)
Table 63. Middle East & Africa Infertility Therapies Revenue by Application (2016-2021) & (USD Million)
Table 64. Middle East & Africa Infertility Therapies Revenue by Application (2021-2026) & (USD Million)
Table 65. Middle East & Africa Infertility Therapies Revenue by Country (2016-2021) & (USD Million)
Table 66. Middle East & Africa Infertility Therapies Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Infertility Therapies Picture
Figure 2. Global Infertility Therapies Revenue Market Share by Type in 2020
Figure 3. Female Infertility Testing
Figure 4. Male Infertility Testing
Figure 5. Infertility Therapies Revenue Market Share by Application in 2020
Figure 6. Hospitals Picture
Figure 7. Clinics Picture
Figure 8. Fertility Centers Picture
Figure 9. Others Picture
Figure 10. Global Infertility Therapies Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 11. Global Infertility Therapies Revenue and Forecast (2016-2026) & (USD Million)
Figure 12. Global Infertility Therapies Revenue Market Share by Region (2016-2026)
Figure 13. Global Infertility Therapies Revenue Market Share by Region in 2020
Figure 14. North America Infertility Therapies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 15. Europe Infertility Therapies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Asia-Pacific Infertility Therapies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. South America Infertility Therapies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Middle East and Africa Infertility Therapies Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Infertility Therapies Market Drivers
Figure 20. Infertility Therapies Market Restraints
Figure 21. Infertility Therapies Market Trends
Figure 22. Merck Recent Developments and Future Plans
Figure 23. Abbott Recent Developments and Future Plans
Figure 24. BioMerieux Recent Developments and Future Plans
Figure 25. BioZhena Recent Developments and Future Plans
Figure 26. Ferring Pharmaceuticals Recent Developments and Future Plans
Figure 27. Global Infertility Therapies Revenue Share by Players in 2020
Figure 28. Infertility Therapies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 29. Global Top 3 Players Infertility Therapies Revenue Market Share in 2020
Figure 30. Global Top 10 Players Infertility Therapies Revenue Market Share in 2020
Figure 31. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 32. Global Infertility Therapies Revenue Share by Type in 2020
Figure 33. Global Infertility Therapies Market Share Forecast by Type (2021-2026)
Figure 34. Global Infertility Therapies Revenue Share by Application in 2020
Figure 35. Global Infertility Therapies Market Share Forecast by Application (2021-2026)
Figure 36. North America Infertility Therapies Sales Market Share by Type (2016-2026)
Figure 37. North America Infertility Therapies Sales Market Share by Application (2016-2026)
Figure 38. North America Infertility Therapies Revenue Market Share by Country (2016-2026)
Figure 39. United States Infertility Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 40. Canada Infertility Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Mexico Infertility Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Europe Infertility Therapies Sales Market Share by Type (2016-2026)
Figure 43. Europe Infertility Therapies Sales Market Share by Application (2016-2026)
Figure 44. Europe Infertility Therapies Revenue Market Share by Country (2016-2026)
Figure 45. Germany Infertility Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. France Infertility Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. United Kingdom Infertility Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Russia Infertility Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Italy Infertility Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Asia-Pacific Infertility Therapies Sales Market Share by Type (2016-2026)
Figure 51. Asia-Pacific Infertility Therapies Sales Market Share by Application (2016-2026)
Figure 52. Asia-Pacific Infertility Therapies Revenue Market Share by Region (2016-2026)
Figure 53. China Infertility Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Japan Infertility Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. South Korea Infertility Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. India Infertility Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Southeast Asia Infertility Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Australia Infertility Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. South America Infertility Therapies Sales Market Share by Type (2016-2026)
Figure 60. South America Infertility Therapies Sales Market Share by Application (2016-2026)
Figure 61. South America Infertility Therapies Revenue Market Share by Country (2016-2026)
Figure 62. Brazil Infertility Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Argentina Infertility Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Middle East and Africa Infertility Therapies Sales Market Share by Type (2016-2026)
Figure 65. Middle East and Africa Infertility Therapies Sales Market Share by Application (2016-2026)
Figure 66. Middle East and Africa Infertility Therapies Revenue Market Share by Country (2016-2026)
Figure 67. Turkey Infertility Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Saudi Arabia Infertility Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. UAE Infertility Therapies Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Methodology
Figure 71. Research Process and Data Source
女性不妊薬の世界市場 2019年版：種類別（非経口、経口、その他）、用途別（卵巣過刺激症候群、多胎妊娠、多産児、早産、低出生体重、帝王切開リスク） Scope of the Report: The global Female Infertility Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, …- 男性不妊症用診断及び治療市場：世界及び中国市場分析・予測（～2024年） Male Infertility Diagnosis and Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Male Infertility Diagnosis and Treatment industry with a focus on the Chinese market. The report provides key statistics on the market st…
- 不妊治療市場：世界及び中国市場分析・予測（～2024年） Infertility Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Infertility Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Infertility Treatment manu…
- 世界の重症筋無力症治療市場 2021：企業別、地域別、種類・用途別 The Myasthenia Gravis Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…
- 世界の緑内障レーザー治療市場 2021：企業別、地域別、種類・用途別 The Glaucoma Laser Therapies market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regula…